Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA grants fast track designation to intrathecally idursulfase

Jan. 26, 2015

FDA accepts Praluent BLA for priority review

Jan. 26, 2015

EMA committee recommends approval of Saxenda for weight management

Jan. 26, 2015

Senshio approved in Europe for vulvar and vaginal atrophy

Jan. 26, 2015

Selective cannabinoid CB1 receptor antagonism improves diabetic nephropathy

Jan. 26, 2015

Sichuan Haisco Pharmaceutical presents SGLT2 inhibitors for diabetes

Jan. 23, 2015

Merck KGaA prepares positive allosteric modulators for infertility

Jan. 23, 2015

Japan Tobacco divulges PDHK inhibitors

Jan. 23, 2015

EMA accepts AstraZeneca's lesinurad MAA for gout

Jan. 22, 2015

European Commission approves Cerdelga for type 1 Gaucher's disease

Jan. 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...